I have been a non-executive director of the business since it's inception in 2021. As pressure continues on NHS General Practice there is an increasing demand for private GPs. I led the practice as it expanded into new services and operational areas.This interim role involves all the classical business expansion activities with a strong emphasis on people development, service offering expansion and regulatory compliance. Operationally the business also needs reinforcing in the disciplines of finance, marketing, strategy, customer service and operations.The business enjoys fantastic customer feedback and the essence of providing a people driven, patient centric service is something I am really pleased to have as the foundations of this exciting venture.

I was recruited to create and lead TVM UK Animal Health (the veterinary channel brand of Domes Pharma) and launch Domes Pharma into the UK animal health market. This was the first overseas subsidiary for the group and presented them with all the challenges that come with internationalisation. Over a 6 year period the UK team grew to 28 people, launched multiple products to become a top 20 player and the undisputed market leader in toxicology. The role challenged all aspects of my skills and experience to date. I hugely enjoyed balancing the creativity and chaos of new venture creation with the financial and regulatory discipline needed in this highly regulated sector. Simultaneously I also worked with some amazing colleagues all across Domes Pharma breaking down the cultural, geographical and language barriers all international companies experience Recruiting and motivating people was a large part of the role. I made it my mission to create the conditions for them to have the opportunity to excel and, as we grew I was constantly thinking how to put them in positions that played to their strengths. Trusting and empowering the people who worked at the front line of all areas of the business was a key success factor for the business. My biggest satisfaction was creating a safe, "learn to fail fast and move on" approach and seeing people enjoying their roles and growing with the business.

This young, dynamic UK arm of the well respected Australian vet pharma company was taking a refreshing and innovative approach to developing its business. Jurox had recently established a direct presence in the UK to support and underline their commitment to the field of veterinary anaesthesia. This role involved providing strategic input, field team leadership, marketing and partnership based engagement with key accounts. Working with a team of highly trained vets who have additional in-depth training in anaesthesia this position was developed to ensure that the team maximized Jurox's impact and delivers on their mission to enable all veterinary practices to have access to the tools and techniques to perform best practice anaesthesia in a diverse range of circumstances.

Jurox had recently established a direct presence in the UK to support and underline their commitment to the field of veterinary anaesthesia. This young, dynamic UK arm of the well respected Australian vet pharma company was taking a refreshing and innovative approach to developing its business. Working with a team of highly trained vets who have additional in-depth training in anaesthesia this position was developed to ensure that the team maximizes Jurox's impact and deliverd on their mission to enable all veterinary practices to have access to the tools and techniques to perform best practice anaesthesia in a diverse range of circumstances.

Using operational management, marketing, strategic and veterinary expertise this role was introduced to develop the Midland's flagship centre of this dynamic veterinary company that aims deliver a wide range of affordable veterinary care.Providing leadership at a time of exceptionally rapid growth and change within this corporate veterinary group the role involved developing and implementing strategies that stretch the boundaries of affordable, quality pet care.

This service operations consultancy project was devised to develop lean within service delivery area of this dynamic rapidly growing corporate groups that aims to deliver affordable veterinary care. The project analysed how to eliminate waste and optimize the use of resources within the organisation to deliver on the YourVets promise to provide veterinary care in a more affordable way.

Currently completing a full time MBA at Warwick Business School. Dean's listed for excellent overall Academic performance in Term1 Dean's listed for excellent overall Academic performance Term 2Member of the award winning Practice Of Managent team for work with a local Charity

• Promoted to the senior management team to establish a dedicated marketing department including recruitment of key staff.• Responsible for marketing the entire company portfolio (sales of over £20m equivalent/year) and an expenditure of £1.7m across 2 countries.• Designed systems and processes for key activities such as forecasting, budgeting, strategic planning and media buying. • Designed KPIs to measure key performance in areas of market share, market development, purchasing behaviour, budget control, communications quality, PR coverage, sales forecasting and deadline adherence.• Developed Marbocyl, the company’s mission critical brand to no.1 in segment• Led department to key successes; including winning the company prize for best contribution to increasing efficiency by using novel approaches such as teambuilding with a local charity and reducing cost per event of a major educational programme through using an innovative venue selection strategy.• Twice winners in Vetoquinol’s international marketing awards. • Launched a novel anaesthetic induction agent in 2006 that has been the fastest growing product on the market for every year since launch attaining no.2 market position in 2010

• Launched five key brands including Clavaseptin Palatable Tablets which grew to be the no.2 brand in the companion animal portfolio contributing 25% to sector sales. This launch included contributing significantly to the international product strategy and concept during pre-launch. This was achieved by detailed customer analysis revealing new insights into unmet needs in the market segment and by persuading the international development team to make changes to the pack sizes and product name.• Participated in successful negotiations with a distributor for novel anaesthetic distribution in contract by providing convincing strategic argumentation for target markets influencing the manufacturer to appoint the company as the preferred distribution partner.• Conceived and managed the team that delivered a highly successful professional education programme for customers with a user endorsement in excess of 90%• Won best show stand at the British Small Animal Veterinary Association’s annual congress, Birmingham, UK, 2004 (The largest Animal Health industry congress in the world)• Elected to represent the industry views as member of the Technical and Strategic Affairs Committee of the National Office of Animal Health, the animal health industry body. Appointment to this highly influential committee from 2005-2011 was a unique opportunity to get a mid to long rang view of many of the issues faced by the industry and provided significant strategic advantage through detailed first-hand knowledge of the issues. It allowed the company to influence the views of the organisation and also provided access to an excellent network within the industry and the regulatory body with whom the committee members had frequent access.